The abstract is read at the publisher; the summary is JClub's.
Early-onset breast cancer diagnosed before 50 years of age is linked to rising global incidence and disproportionately unfavourable outcomes, driven by more than inherited susceptibility alone.
- Why it matters: Genetics does not explain the increasing incidence and persistent disparities in EOBC, so risk assessment and care pathways need to incorporate tumour biology, exposures, and healthcare constraints.
- What they did: This Review synthesizes epidemiological trends on inherited and multifactorial risk determinants, tumour subtype distributions, and modifiable exposures, and evaluates why age-based screening misses EOBC risk.
- The result: It proposes a roadmap integrating family history, germline testing, ancestry-aware risk models, biomarker-guided diagnosis, and resource-stratified implementation to improve prompt, equitable management and outcomes.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.